Literature DB >> 22096090

Temporal trends of the gaps in post-myocardial infarction secondary prevention strategies of co-morbid and elderly populations vs. younger counterparts: an analysis of three successive cohorts between 2003 and 2008.

Alejandro Macchia1, Marilena Romero, Antonio D'Ettorre, Javier Mariani, Gianni Tognoni.   

Abstract

Aims Epidemiological studies reported two contrasting trends: on one hand, a significant improvement in the use of evidence-based treatments of patients discharged with a myocardial infarction (MI). On the other hand, the increasing number of elderly and co-morbid patients who are usually less treated. The aim of this study is to examine whether improvements in the treatment of MI are homogeneously distributed throughout all subgroups of patients. Methods and results Based on record linkage of administrative registers, 21 423 patients discharged with MI in three different periods (2003, 2005, and 2007), were identified and followed up for major clinical events up to 1 year. Using as a reference temporal category those patients discharged in 2003 (odds ratios, 95% confidence intervals) and as a demographic category male patients aged ≤75 years (1.00), the study identified: in-hospital mortality significantly decreased in all periods and in all groups of patients; out-of-hospital mortality decreased only in younger patients and not in older patients; prescription of evidence-based treatments increased in all periods for all patients; however, the magnitude of improvement was mostly concentrated in younger patients. Conclusion Although there was a mean improvement in the treatment and outcome of patients discharged from an MI, most of these benefits were strongly concentrated in younger, healthier patients. Old and co-morbid populations-although representing a substantial proportion of the burden of disease-received significant less attention and barely improved their survival.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22096090     DOI: 10.1093/eurheartj/ehr410

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  8 in total

1.  On the hypothetical universal use of statins in primary prevention: an observational analysis on low-risk patients and economic consequences of a potential wide prescription rate.

Authors:  Alejandro Macchia; Javier Mariani; Marilena Romero; Fabio Robusto; Vito Lepore; Antonio Dettorre; Gianni Tognoni
Journal:  Eur J Clin Pharmacol       Date:  2015-02-11       Impact factor: 2.953

2.  The changing epidemiology of myocardial infarction in Olmsted County, Minnesota, 1995-2012.

Authors:  Yariv Gerber; Susan A Weston; Ruoxiang Jiang; Véronique L Roger
Journal:  Am J Med       Date:  2014-09-28       Impact factor: 4.965

3.  The long-term effects of stillbirth on women with and without gestational diabetes: a population-based cohort study.

Authors:  Basilio Pintaudi; Giuseppe Lucisano; Fabio Pellegrini; Antonio D'Ettorre; Vito Lepore; Giorgia De Berardis; Marco Scardapane; Giacoma Di Vieste; Maria Chiara Rossi; Michele Sacco; Gianni Tognoni; Antonio Nicolucci
Journal:  Diabetologia       Date:  2014-10-14       Impact factor: 10.122

4.  Secondary prevention medication after myocardial infarction: persistence in elderly people over the course of 1 year.

Authors:  Saba Al-Khadra; Christa Meisinger; Ute Amann; Rolf Holle; Bernhard Kuch; Hildegard Seidl; Inge Kirchberger
Journal:  Drugs Aging       Date:  2014-07       Impact factor: 3.923

5.  Sex Differences in Cardiovascular Medication Prescription in Primary Care: A Systematic Review and Meta-Analysis.

Authors:  Min Zhao; Mark Woodward; Ilonca Vaartjes; Elizabeth R C Millett; Kerstin Klipstein-Grobusch; Karice Hyun; Cheryl Carcel; Sanne A E Peters
Journal:  J Am Heart Assoc       Date:  2020-05-20       Impact factor: 5.501

6.  Cancer Incidence and Mortality According to Pre-Existing Heart Failure in a Community-Based Cohort.

Authors:  Edoardo Bertero; Fabio Robusto; Eliana Rulli; Antonio D'Ettorre; Lucia Bisceglia; Lidia Staszewsky; Christoph Maack; Vito Lepore; Roberto Latini; Pietro Ameri
Journal:  JACC CardioOncol       Date:  2022-01-18

7.  Monocytes as a convergent nanoparticle therapeutic target for cardiovascular diseases.

Authors:  Dasia Aldarondo; Elizabeth Wayne
Journal:  Adv Drug Deliv Rev       Date:  2022-01-24       Impact factor: 17.873

8.  NT-proBNP best predictor of cardiovascular events and cardiovascular mortality in secondary prevention in very old age: the Leiden 85-plus Study.

Authors:  Petra G van Peet; Yvonne M Drewes; Anton J M de Craen; Jacobijn Gussekloo; Wouter de Ruijter
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.